Pfizer Ventures

About The Fund

Pfizer Ventures is the corporate venture capital arm of Pfizer Inc, specializing in investments across the healthcare industry in the United States. They have a strong focus on early-stage companies but are open to investing in businesses at all stages of development, including startups and spinouts. Their investment portfolio mainly concentrates on transformative therapeutics and is particularly interested in the areas of Inflammation & Immunology, Internal Medicine, Oncology, Anti-Infectives, and Vaccines. They are also open to exploring platform technologies, diagnostics, drug delivery, pharmaceutical services, and other technologies capable of significantly advancing drug discovery and development. Pfizer Ventures actively supports their portfolio companies by offering strategic guidance alongside capital investment and can bring pharmaceutical insights by potentially leveraging Pfizer's internal networks and expertise. With a significant capital commitment of $900 million, they're equipped for substantial initial investments and reserve the ability to follow-on. Although primarily focused on the U.S., they allocate approximately 20% of their investments internationally. Pfizer Ventures positions itself as an active investor, contributing industry experience to help guide companies in their growth. This includes scientific advisory board participation and seeking board representation wwhere appropriate, with an emphasis on maintaining minority ownership positions. They do not require product rights as part of their investment deal structure. The company also stresses the potential symbiosis between investment and strategic business relationships with Pfizer, which can either be considered at the time of investment or in the future. With assets under management amounting to $6.8 billion, their financial objectives include both strategic and financial returns, measured over the long term. The firm's expertise spans equity investments with particular specializations in Expansion, MBO/LBO, Restructuring, PIPE, and Privatization. Pfizer Ventures is headquartered in Beijing, China, with a Venture Capital Fund as its primary investment type.